Sector
PharmaceuticalsOpen
₹1,197Prev. Close
₹1,206.9Turnover(Lac.)
₹115.97Day's High
₹1,231.4Day's Low
₹1,195.8552 Week's High
₹1,607.952 Week's Low
₹660.25Book Value
₹670.72Face Value
₹10Mkt Cap (₹ Cr.)
688.14P/E
9.11EPS
132.08Divi. Yield
0.96Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 5.71 | 5.71 | 5.71 | 5.71 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 377.27 | 305.87 | 273.76 | 238.67 |
Net Worth | 382.98 | 311.58 | 279.47 | 244.38 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Revenue | 320.79 | 287.45 | 295.32 | 322.6 |
yoy growth (%) | 11.59 | -2.66 | -8.45 | 0.25 |
Raw materials | -105.39 | -90.93 | -85.04 | -94.68 |
As % of sales | 32.85 | 31.63 | 28.79 | 29.35 |
Employee costs | -90.33 | -84.53 | -83.17 | -81.6 |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Profit before tax | 28.95 | 21.54 | 27.23 | 22.21 |
Depreciation | -7.67 | -8.23 | -7.51 | -8.99 |
Tax paid | -9.78 | -8.06 | -10.17 | -15.02 |
Working capital | -38.2 | -2.63 | -1.62 | 8.15 |
Other operating items |
Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 11.59 | -2.66 | -8.45 | 0.25 |
Op profit growth | 39.53 | -22.03 | -10.27 | -15.11 |
EBIT growth | 32.79 | -19.91 | 16.44 | 4.6 |
Net profit growth | 94.78 | -38.32 | -66.75 | 250.32 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
A K Kothari
Independent Director
Hemal Kampani
Independent Director
Rajiv Singhi
Director
Prabhawati Devi Kothari
Independent Director
Arindam Sarkar
Independent Director
Shirish Gundopant Belapure
Independent Director
Monjori Mitra
Director
Anand Vardhan Kothari
Company Sec. & Compli. Officer
A B Chakrabarty
Managing Director & CEO
U. M. Kunte
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Albert David Ltd
Summary
Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the Kothari Group. The Companys principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers.ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.90 augmented the long-term working capital. ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.During 1998-99, the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company
Read More
The Albert David Ltd shares price on N/A is Rs.₹1208.05 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Albert David Ltd is ₹689.80 Cr. as of 22 Jul ‘24
The PE and PB ratios of Albert David Ltd is 9.11 and 1.79 as of 22 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Albert David Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Albert David Ltd is ₹662.95 and ₹1605 as of 22 Jul ‘24
Albert David Ltd's CAGR for 5 Years at 26.22%, 3 Years at 31.19%, 1 Year at 79.64%, 6 Month at -2.97%, 3 Month at 7.14% and 1 Month at -7.95%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.